Skip to main content

Table 3 Ordinal logistic regression model

From: Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

Parameters

Univariate analysis

Multivariate analysis

 

OR

95% CI

P

OR

95% CI

P

Age

1.63

1.25 to 2.12

0.0001

1.62

1.24 to 2.13

0.0001

Lenalidomide use

1.4

1.05 to 1.85

0.021

1.2

.89 to 1.63

0.217

Hematological toxicity

4.51

2.92 to 6.97

0.0001

3.9

2.48 to 6.14

0.0001

Baseline cytopenia

1.38

1.03 to 1.85

0.029

1.33

.98 to 1.8

0.062

  1. Univariate and multivariate analysis of risk factors analyzed. Statistical significance was defined as P <0.05. CI, confidence interval; OR odds ratio.